Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14+ cells of giant cell tumor of bone

Sofia Avnet, Manuela Salerno, Nicoletta Zini, Marco Alberghini, Davide Gibellini, Nicola Baldini

Research output: Contribution to journalArticle

Abstract

Giant cell tumor (GCT) of bone is a histologically benign osteolytic tumor featuring prominent osteoclast-like giant cells, mononuclear osteoclast precursors, and spindle-shaped stromal cells (SCs). Thus far, most studies have identified SCs as truly transformed elements that are responsible for sustained giant cell formation via receptor activator of NF-κB ligand (RANKL) paracrine induction. However, we have previously shown that SCs are hyperplastic, rather than neoplastic, and able to induce giant cell formation similar to that of normal mesenchymal SCs; we hypothesized that other cell subsets of GCTs might be primarily relevant for the pathogenesis. In this study, we show that the nonproliferating CD14+ cells of GCTs, exhibiting typical monoblast lineage features, secrete high amounts of RANKL, thereby activating a RANKL/RANK autocrine loop that determines sustained giant cell formation. Moreover, these cells also lack adequate negative feedback control of the RANKL signaling pathway, as determined by endogenous interferon β. These data demonstrate that CD14+ cells of GCTs are abnormally stimulated to limitless differentiation into multinucleated giant cells and provide useful suggestions for the development of novel therapies.

Original languageEnglish
Pages (from-to)1357-1366
Number of pages10
JournalAmerican Journal of Pathology
Volume182
Issue number4
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Giant Cell Tumor of Bone
Giant Cells
Osteogenesis
Stromal Cells
Osteoclasts
Monocyte-Macrophage Precursor Cells
Mesenchymal Stromal Cells
Interferons
Ligands
Neoplasms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14+ cells of giant cell tumor of bone. / Avnet, Sofia; Salerno, Manuela; Zini, Nicoletta; Alberghini, Marco; Gibellini, Davide; Baldini, Nicola.

In: American Journal of Pathology, Vol. 182, No. 4, 04.2013, p. 1357-1366.

Research output: Contribution to journalArticle

Avnet, Sofia ; Salerno, Manuela ; Zini, Nicoletta ; Alberghini, Marco ; Gibellini, Davide ; Baldini, Nicola. / Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14+ cells of giant cell tumor of bone. In: American Journal of Pathology. 2013 ; Vol. 182, No. 4. pp. 1357-1366.
@article{4b4ad0588cce47fe9fa9437dc2feeace,
title = "Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14+ cells of giant cell tumor of bone",
abstract = "Giant cell tumor (GCT) of bone is a histologically benign osteolytic tumor featuring prominent osteoclast-like giant cells, mononuclear osteoclast precursors, and spindle-shaped stromal cells (SCs). Thus far, most studies have identified SCs as truly transformed elements that are responsible for sustained giant cell formation via receptor activator of NF-κB ligand (RANKL) paracrine induction. However, we have previously shown that SCs are hyperplastic, rather than neoplastic, and able to induce giant cell formation similar to that of normal mesenchymal SCs; we hypothesized that other cell subsets of GCTs might be primarily relevant for the pathogenesis. In this study, we show that the nonproliferating CD14+ cells of GCTs, exhibiting typical monoblast lineage features, secrete high amounts of RANKL, thereby activating a RANKL/RANK autocrine loop that determines sustained giant cell formation. Moreover, these cells also lack adequate negative feedback control of the RANKL signaling pathway, as determined by endogenous interferon β. These data demonstrate that CD14+ cells of GCTs are abnormally stimulated to limitless differentiation into multinucleated giant cells and provide useful suggestions for the development of novel therapies.",
author = "Sofia Avnet and Manuela Salerno and Nicoletta Zini and Marco Alberghini and Davide Gibellini and Nicola Baldini",
year = "2013",
month = "4",
doi = "10.1016/j.ajpath.2012.12.021",
language = "English",
volume = "182",
pages = "1357--1366",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14+ cells of giant cell tumor of bone

AU - Avnet, Sofia

AU - Salerno, Manuela

AU - Zini, Nicoletta

AU - Alberghini, Marco

AU - Gibellini, Davide

AU - Baldini, Nicola

PY - 2013/4

Y1 - 2013/4

N2 - Giant cell tumor (GCT) of bone is a histologically benign osteolytic tumor featuring prominent osteoclast-like giant cells, mononuclear osteoclast precursors, and spindle-shaped stromal cells (SCs). Thus far, most studies have identified SCs as truly transformed elements that are responsible for sustained giant cell formation via receptor activator of NF-κB ligand (RANKL) paracrine induction. However, we have previously shown that SCs are hyperplastic, rather than neoplastic, and able to induce giant cell formation similar to that of normal mesenchymal SCs; we hypothesized that other cell subsets of GCTs might be primarily relevant for the pathogenesis. In this study, we show that the nonproliferating CD14+ cells of GCTs, exhibiting typical monoblast lineage features, secrete high amounts of RANKL, thereby activating a RANKL/RANK autocrine loop that determines sustained giant cell formation. Moreover, these cells also lack adequate negative feedback control of the RANKL signaling pathway, as determined by endogenous interferon β. These data demonstrate that CD14+ cells of GCTs are abnormally stimulated to limitless differentiation into multinucleated giant cells and provide useful suggestions for the development of novel therapies.

AB - Giant cell tumor (GCT) of bone is a histologically benign osteolytic tumor featuring prominent osteoclast-like giant cells, mononuclear osteoclast precursors, and spindle-shaped stromal cells (SCs). Thus far, most studies have identified SCs as truly transformed elements that are responsible for sustained giant cell formation via receptor activator of NF-κB ligand (RANKL) paracrine induction. However, we have previously shown that SCs are hyperplastic, rather than neoplastic, and able to induce giant cell formation similar to that of normal mesenchymal SCs; we hypothesized that other cell subsets of GCTs might be primarily relevant for the pathogenesis. In this study, we show that the nonproliferating CD14+ cells of GCTs, exhibiting typical monoblast lineage features, secrete high amounts of RANKL, thereby activating a RANKL/RANK autocrine loop that determines sustained giant cell formation. Moreover, these cells also lack adequate negative feedback control of the RANKL signaling pathway, as determined by endogenous interferon β. These data demonstrate that CD14+ cells of GCTs are abnormally stimulated to limitless differentiation into multinucleated giant cells and provide useful suggestions for the development of novel therapies.

UR - http://www.scopus.com/inward/record.url?scp=84875135728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875135728&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2012.12.021

DO - 10.1016/j.ajpath.2012.12.021

M3 - Article

C2 - 23395086

AN - SCOPUS:84875135728

VL - 182

SP - 1357

EP - 1366

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

ER -